title: Corneal Cross-linking for Keratoconus: A Look at the Data, the Food and Drug Administration, and the Future.
authors: Baltimore, Maryland. Electronic address: bjeng@som.umaryland.edu.
authors: Bennie H
authors: BH
authors: Jeng
authors: Irvine, California.
authors: Marjan
authors: M
authors: Farid
authors: Rochester, Minnesota.
authors: Sanjay V
authors: SV
authors: Patel
authors: Sacramento, California.
authors: Ivan R
authors: IR
authors: Schwab
mesh_terms: D002986:Clinical Trials as Topic; D003094:Collagen / Q000378:metabolism; D003319:Corneal Stroma / Q000378:metabolism; D003432:Cross-Linking Reagents; D017277:Drug Approval; D005544:Forecasting; D006801:Humans; D007640:Keratoconus / Q000188:drug therapy* / Q000378:metabolism; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000627:therapeutic use*; D012107:Research Design; D012256:Riboflavin / Q000627:therapeutic use*; D014466:Ultraviolet Rays; D014481:United States; D014486:United States Food and Drug Administration / Q000639:trends*
chemical_list: D003432:Cross-Linking Reagents; D017319:Photosensitizing Agents; D003094:Collagen; D012256:Riboflavin